Ascend
Ascend was founded to address the need for quality manufacturing capacity for any gene and cell therapy developer.
Ascend has raised €121M across 1 funding round, most recently a round in May 2023. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.
London, UKwww.ascend-gctx.com ↗
Total raised
€121M
€120,905,192
Funding rounds
1
Investors
0
distinct backers
Active since
2023-05
latest 2023-05
Funding by year
EUR raised per yearAscend — funding by year — interactive chart.
Data table
| Ascend — funding by year | |
|---|---|
| 2023 | €121M |
Signals
Medium confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Past typical raise window
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-05-09 | Other | €121M | — | View deal → |